Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.
A trial looking at a different way of giving posaconazole to prevent fungal infection after treatment for some blood cancers
More about this trial
Doctors can treat AML, MDS and CML with chemotherapy or a bone marrow or stem cell transplant. One of the side effects of both these treatments is a drop in white blood cells causing an increased risk of infection, including fungal infection.
Posaconazole is a drug that doctors use to treat or prevent fungal infection. It is a liquid that you swallow. The researchers developed another form of posaconazole that you have as a
The aims of this trial were to find out the
- Levels of posaconazole in the blood before and after having it through a drip
- Side effects of having posaconazole through a drip
- Levels of posaconazole in the blood after switching from having it as a drip to a liquid that is swallowed
Summary of results
Despite attempting to contact the trial team, we have not been able to have the results for this trial checked.
How to join a clinical trial
Dr Samir Agrawal
Merck, Sharp & Dohme
Schering Plough Research Institute